Ezcorp Inc: Form 10-Q for the period ended Jun 30, 2024
Filed with the SEC on Jul 31, 2024 and accepted by EDGAR at Jul 31, 2024, 16:10 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-04-01 to 2024-06-30 | $281.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-10-01 to 2024-06-30 | $867.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Gross profit | 3 months2024-04-01 to 2024-06-30 | $166.7m | us-gaap:GrossProfit |
| Gross profit | 9 months2023-10-01 to 2024-06-30 | $506.9m | us-gaap:GrossProfit |
| Operating income | 3 months2024-04-01 to 2024-06-30 | $22.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-10-01 to 2024-06-30 | $86.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-04-01 to 2024-06-30 | $3.5m | us-gaap:InterestExpense |
| Interest expense | 9 months2023-10-01 to 2024-06-30 | $10.4m | us-gaap:InterestExpense |
| Income tax | 3 months2024-04-01 to 2024-06-30 | $5.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-10-01 to 2024-06-30 | $21.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-04-01 to 2024-06-30 | $17.9m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-10-01 to 2024-06-30 | $67.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-04-01 to 2024-06-30 | $0.25 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-10-01 to 2024-06-30 | $0.89 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-04-01 to 2024-06-30 | $0.33 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-10-01 to 2024-06-30 | $1.23 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-04-01 to 2024-06-30 | 83,008,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-10-01 to 2024-06-30 | 84,309,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-10-01 to 2024-06-30 | $70.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-10-01 to 2024-06-30 | $16.9m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 9 months2023-10-01 to 2024-06-30 | $9.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-06-30 | $218.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-06-30 | $741.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-06-30 | $1.51bn | us-gaap:Assets |
| Current liabilities | At period end2024-06-30 | $286.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-06-30 | $708.7m | us-gaap:Liabilities |
| Long-term debt | At period end2024-06-30 | $224.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-06-30 | $137.3m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2024-06-30 | $801.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000876523-24-000025. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.